Dr. Patrick Thomas Duffy, D.D.S, Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10541 N Ranch Rd, Hayward, WI 54843 Phone: 715-634-2011 Fax: 715-634-1352 |
Peter E Rydell, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15704 W Us Highway 63, Hayward, WI 54843 Phone: 715-634-4864 Fax: 715-634-6305 |
Mrs. Laura Channing, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 15910 W Company Lake Rd, Hayward, WI 54843 Phone: 715-934-2224 Fax: 715-934-5740 |
Kay E Hawksford, DDS Dentist Medicare: Medicare Enrolled Practice Location: 15541 Highway 77 E, Hayward, WI 54843 Phone: 715-634-6776 Fax: 715-634-5859 |
Dr. Thomas Lynn Holloway, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15601 Railroad St, Woodland Ct Ste 303, Hayward, WI 54843 Phone: 715-634-4444 |
Dr. Kyra Rhodes Larson, DDS Dentist Medicare: Medicare Enrolled Practice Location: 15541w Hwy 77 East, Hayward, WI 54843 Phone: 715-634-6776 Fax: 715-634-5859 |
Dr. Thomas Erwin Tadysak, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10610 Main St, Hayward, WI 54843 Phone: 715-638-3403 |
Dr. John Keith Syverson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15601 Railroad St, Ste 303, Hayward, WI 54843 Phone: 715-631-4444 Fax: 715-634-4444 |
News Archive
Not all dietary supplements and "alternative" products are harmless though. German Institute urges consumers to be more critical of health claims.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
The coronavirus pandemic has rippled across the globe, infecting nearly 18 million individuals worldwide to date. Though the coronavirus disease (COVID-19) affects people from all walks of life, women and girls may experience devastating effects of the outbreak.
Researchers identified a single enzyme doing the work of a trio thought necessary to control a common cellular signaling process being pursued as a therapeutic target.
Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.
› Verified 4 days ago